These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29165633)

  • 1. Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients.
    Rosenberg BR; Freije CA; Imanaka N; Chen ST; Eitson JL; Caron R; Uhl SA; Zeremski M; Talal A; Jacobson IM; Rice CM; Schoggins JW
    J Infect Dis; 2018 Jan; 217(4):650-655. PubMed ID: 29165633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
    Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
    J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.
    Holmes JA; Congiu M; Bonanzinga S; Sandhu MK; Kia YH; Bell SJ; Nguyen T; Iser DM; Visvanathan K; Sievert W; Bowden DS; Desmond PV; Thompson AJ
    Aliment Pharmacol Ther; 2015 Aug; 42(3):296-306. PubMed ID: 26032235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection.
    Monteleone K; Scheri GC; Statzu M; Selvaggi C; Falasca F; Giustini N; Mezzaroma I; Turriziani O; d'Ettorre G; Antonelli G; Scagnolari C
    Arch Virol; 2016 Nov; 161(11):3263-8. PubMed ID: 27558125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
    Amanzada A; Reinhardt L; Fey D; Zeisberg EM; Mihm S
    PLoS One; 2015; 10(11):e0143783. PubMed ID: 26606750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
    Amanzada A; Kopp W; Spengler U; Ramadori G; Mihm S
    PLoS One; 2013; 8(12):e84026. PubMed ID: 24376784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
    Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y
    J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients.
    Bordi L; Caglioti C; Garbuglia AR; Lapa D; Castilletti C; Taibi C; Capobianchi MR; Lalle E
    PLoS One; 2015; 10(2):e0117397. PubMed ID: 25675103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?
    O'Brien TR; Jackson SS
    J Interferon Cytokine Res; 2019 Oct; 39(10):618-626. PubMed ID: 31161939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
    Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P
    Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels.
    Jouvin-Marche E; Macek Jílková Z; Thelu MA; Marche H; Fugier E; Van Campenhout N; Hoang XS; Marlu A; Sturm N; Callanan M; Leroy V; Zarski JP; Marche PN
    J Infect Dis; 2014 Jun; 209(12):1907-15. PubMed ID: 24415789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic
    Huschka H; Mihm S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of interferon alpha inducible genes in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus and healthy donors.
    MacParland SA; Corkum CP; Burgess C; Karwowska S; Kroll W; Michalak TI
    Int Immunopharmacol; 2015 Apr; 25(2):545-52. PubMed ID: 25765354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
    Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
    BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFNL4: Notable variants and associated phenotypes
    Fang MZ; Jackson SS; O'Brien TR
    Gene; 2020 Mar; 730():144289. PubMed ID: 31846709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin.
    Petersen T; Lee YJ; Osinusi A; Amorosa VK; Wang C; Kang M; Matining R; Zhang X; Dou D; Umbleja T; Kottilil S; Peters MG
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):660-7. PubMed ID: 26974581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden.
    Lu YF; Goldstein DB; Urban TJ; Bradrick SS
    Virology; 2015 Feb; 476():334-340. PubMed ID: 25577150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated interferons Lambda-1a and alfa-2a display different gene induction and cytokine and chemokine release profiles in whole blood, human hepatocytes and peripheral blood mononuclear cells.
    Freeman J; Baglino S; Friborg J; Kraft Z; Gray T; Hill M; McPhee F; Hillson J; Lopez-Talavera JC; Wind-Rotolo M
    J Viral Hepat; 2014 Jun; 21(6):e1-9. PubMed ID: 24827902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The
    Zhou H; Møhlenberg M; Terczyńska-Dyla E; Winther KG; Hansen NH; Vad-Nielsen J; Laloli L; Dijkman R; Nielsen AL; Gad HH; Hartmann R
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31776283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 ΔG allele with higher HCV RNA decline during the first 4 weeks of pegylated interferon and ribavirin therapy in HCV-1 patients.
    Galmozzi E; Aghemo A
    J Clin Virol; 2014 Apr; 59(4):274-5. PubMed ID: 24495847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.